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Background: Calcium-dependent activation of TRESK is mediated by calcineurin.
Results: The sensitivity of human TRESK to calcium is determined by the LQLP calcineurin-docking site.
Conclusion: The previously known PQIIIS and the novel LQLP sites cooperate for the regulation.
Significance:TRESK-induced hyperpolarization of themembrane potential is influenced by the LQLP-calcineurin interaction.
Calcium-dependent activation of human TRESK (TWIK-re-
lated spinal cord K channel, K2P18.1) depends on direct tar-
getingof calcineurin to thePQIIISmotif. In thepresent studywe
demonstrate that TRESK also contains another functionally rel-
evant docking site for the phosphatase, the LQLP amino acid
sequence. Combined mutations of the PQIIIS and LQLPmotifs
were required to eliminate the calcium-dependent regulation of
the channel. In contrast to the alanine substitutions of PQIIIS,
the mutation of LQLP to AQAP alone did not significantly
change the amplitude of TRESK activation evoked by the sub-
stantial elevation of cytoplasmic calcium concentration. How-
ever, the AQAP mutation slowed down the response to high
calcium. In addition, modest elevation of [Ca2], which effec-
tively regulated the wild type channel, failed to activate TRESK-
AQAP. This indicates that the AQAP mutation diminished the
sensitivity of TRESK to calcium. Even if PQIIIS was replaced by
the PVIVIT sequence of high calcineurin binding affinity, the
effect of the AQAP mutation was clearly detected in this
TRESK-PVIVIT context. Substitution of the LQLP region with
the corresponding fragment of NFAT transcription factor, per-
fectly matching the previously described LXVP calcineurin-
binding consensus sequence, increased the calcium-sensitivity
of TRESK-PVIVIT. Thus the enhancement of the affinity of
TRESK for calcineurin by the incorporation of PVIVIT could
not compensate for or prevent the effects of LQLP sequence
modifications, suggesting that the two calcineurin-binding
regions play distinct roles in the regulation. Our results indicate
that the LQLP site is a fundamental determinant of the calcium-
sensitivity of human TRESK.
Background (leak) potassium channels are responsible for
the hyperpolarizing outward potassium flux in a great variety of
native cell types (1–5). Members of the K2P channel family,
characterized by four transmembrane segments and two pore-
loop forming domains (4TM/2P) in each subunit of the func-
tional dimer, give rise to background K conductance. Among
the fifteen members of this K channel family, TWIK-related
spinal cord K channel, K2P18.1 (TRESK)2 is the only one that
is regulated (i.e. substantially activated) by the elevation of cyto-
plasmic calcium concentration (6–9).
Activation of TRESK does not depend on the direct binding
of calcium ion to the channel. We previously reported that the
calcium/calmodulin-dependent protein phosphatase calcineu-
rin mediates the effect (6). Three serine residues (Ser-264, Ser-
274, and Ser-276) have been identified by alanine-scanning
mutagenesis as the putative targets of the phosphatase in the
mouse channel (6, 8, 10). These residues are also conserved in
human TRESK as Ser-252, Ser-262, and Ser-264. The first ser-
ine is phosphorylated by protein kinaseA (10), and this reaction
permits the binding of 14-3-3 adapter protein (10, 11). Micro-
tubule-affinity regulating (MARK) kinases are currently the
only known enzymes that phosphorylate the other two serines
of functional importance. Accordingly, the overexpression of
MARK accelerates the return of the K current to the resting
state after the calcium-dependent activation of TRESK inXeno-
pus oocytes (8).
In addition to the enzymatic interaction, calcineurin is
directly anchored to a PXIXIT-like site in TRESK (whereXmay
be any amino acid) (12). This mechanism for the targeting of
the phosphatase is unparalleled within the ion channel super-
family. The PXIXIT consensusmotif was originally described in
Nuclear Factor of Activated T cells (NFAT), and later its func-
tional significance was also reported in several other calcineu-
rin-binding proteins (13, 14). The affinities of the PQIIIS and
PQIVID sequences of human and mouse TRESK channels for
calcineurin (KD of 5 or 10M, respectively) proved to be higher
than that of NFAT (KD  25 M for PRIEIT of NFAT1, also
called NFATc2) (14). However, they did not reach the value
characteristic for the optimized PXIXIT sequence, the VIVIT
peptide (KD  0.5 M) (14, 15). The VIVIT peptide binds to a
surface of calcineurin A subunit, distinct from the catalytic site,
as apparent in the crystal structure of the complex (PDB entry* This work was supported by the Hungarian National Research Fund (OTKA
K108496).
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2P6B, (16)). In good accordance with this arrangement, the
PQIIIS motif (Pro at position 200) is located sufficiently far
from the substrate serines in the cytoplasmic loop of TRESK.
Thus the catalytic site of docked calcineurin may reach and
dephosphorylate the substrate residues.
Mutation of PQIVID to PQAVAD in mouse TRESK com-
pletely prevented the calcium-dependent activation of the K
current, indicating that the docking of calcineurin to the chan-
nel is a prerequisite of the regulation (12). Unexpectedly,
humanTRESKbehaved differently from its rodent counterpart.
The PQAAAS mutant, in which all three isoleucines of the
PQIIIS motif were replaced by alanines, was still stimulated by
the calcium ionophore ionomycin. Because the PQIIIS site was
certainly destroyed by the triple A mutation, we hypothesized
that there may be another calcineurin-targeting sequence in
human TRESK.
In addition to PXIXIT, a second calcineurin-binding motif
was also identified in NFAT transcription factors (17–19). This
motif is described by the LXVP consensus sequence, and its
instances have also been found in other proteins (13, 14, 20).
The LXVPmotif was predicted to bind to a hydrophobic cleft at
the interface of calcineurin A and B subunits (20, 21). This
region is different from the surface binding to PXIXIT and also
from the catalytic site. Thus calcineurin can simultaneously
associate to the PXIXIT and LXVPmotifs in the same interact-
ing protein (20, 21). In contrast to PXIXIT, the binding cleft for
LXVP is accessible only in the active conformation of the phos-
phatase (13, 22).
TRESK does not contain a perfect match to the LXVP con-
sensus sequence. Considering that the first leucine and the
fourth prolinemay be the cornerstones of themotif, we decided
to investigate whether the LQLP sequence (Pro at position 243)
constitutes a calcineurin-docking site in human TRESK.
Although no other protein has been known to contain leucine
instead of valine in the third position of the motif, we demon-
strate that LQLP interacts with calcineurin and critically deter-
mines the calcium sensitivity of the channel.
EXPERIMENTAL PROCEDURES
Plasmids and Reagents—The cloning of human and mouse
TRESK cDNAs and their subcloning into the plasmid suitable
for in vitro cRNA synthesis and expression in Xenopus oocytes
was previously described (6). Differentmutant versions of these
constructs were produced with QuikChange site-directed
mutagenesis (Stratagene, La Jolla, CA) according to the man-
ufacturer’s instructions. To obtain GST-hTRESK(174–280)
fusion protein, the coding sequence of fragment 174–280 of
human TRESK was amplified by PCR and subcloned into
pGEX-4T1 (Amersham Biosciences, Little Chalfont, UK)
between the EcoRI and XhoI sites. For the construction of frag-
ment 232–280, this plasmid was cleaved with BamHI and BglII
and the compatible ends were ligated. Both the 174–280 and
the 232–280 fragments contained the additional AAVERPHRD
amino acids at their C terminus in addition to TRESK coding
sequence. Production of GST-mTRESK(164–292) was previ-
ously described (12).
Ionomycin (calcium salt, Enzo Life Sciences, Farmingdale,
NY)was dissolved inDMSOas 5mM stock solution, and diluted
further before the measurement. Carbachol (100 mM) and
VIVITpeptide (3.85mM,NFAT inhibitor, Calbiochem, La Jolla,
CA)were dissolved inwater. Chemicals of analytical gradewere
purchased from Sigma, Fluka, or Merck. Enzymes and kits of
molecular biology applications were purchased from Qiagen
(Chatsworth, CA), Ambion (Austin, TX), Thermo Scientific
(Waltham, MA), New England Biolabs (Beverly, MA), and
Stratagene.
Animals, Tissue Preparation, Xenopus Oocyte Microinjection—
Mouse brain tissue derived fromNMRImouse strain (Toxicop,
Hungary). Xenopus oocytes were prepared, the cRNA was syn-
thesized andmicroinjected as previously described (6). Oocytes
were injected 1 day after defolliculation. Fifty nanoliters of the
appropriate RNA solution was delivered with Nanoliter Injec-
tor (World Precision Instruments, Saratosa, Florida). All treat-
ments of the animals were conducted in accordance with state
laws and institutional regulations. The experiments were
approved by the Animal Care and Ethics Committee of Semmel-
weis University (XIV-I-001/2154-4/2012).
Two-electrode Voltage Clamp Measurements—Two-elec-
trode voltage clamp experiments were performed three or 4
days after the microinjection of cRNA, as described previously
(6). Low [K] solution contained (in mM): NaCl 95.4, KCl 2,
CaCl2 1.8, HEPES 5 (pH 7.5 adjusted with NaOH). High [K]
solution contained 80 mM K (78 mM Na of the low [K]
solution was replaced with K). TRESK background K cur-
rent was measured at the ends of 250 or 300ms voltage steps to
100mVapplied in every 4 s. Because TRESK activation varied
substantially between the different oocyte preparations (e.g.
3.8- or 11-fold activation for wild type TRESK in response to
500 nM ionomycin), groups of oocytes were compared only
from the same preparation in all graphs and calculations.
GST Pulldown Assay—Cerebrum, cerebellum, and brains-
tem from twomicewere homogenized for each experiment in 3
ml of ice cold solution A containing (in mM): KH2PO4 50, NaCl
50,MgCl2 2,-mercaptoethanol 5, PMSF 1, benzamidine 1 (pH
7.0withNaOH), supplementedwith 5%glycerol. The lysatewas
centrifuged at 12,100  g for 20 min at 4 °C. The supernatant
was supplemented with CHAPS (to a final concentration of
1%), andwith EGTA (to a final concentration of 2mM) or CaCl2
(1 mM), and centrifuged at 12,100 g for 10 min.
Glutathione S-transferase (GST) fusion proteins of human
TRESK fragments 174–280 and 232–280, immobilized on 20l
of glutathione-agarose (Sigma), were incubated with the cyto-
sol preparation by gently rotating the beads for 1 h at 4 °C. The
resins were first washed with 1.3 ml of solution A. The second
washing step was a high salt wash for 5 min with solution A
containing 1 MNaCl. The final (third and fourth) washing steps
were also performed with solution A to remove residual salt.
The washing buffers for the first three washing steps were also
supplemented with 1 mM CaCl2 for the assays also containing
Ca2 in the binding reactions. The proteins were eluted from
the resins with SDS sample buffer and separated on 12% Tris-
glycine SDS-PAGE gels, followed by Coomassie Brilliant Blue
staining.
Immunoblot Experiments—Denatured samples were sepa-
rated by SDS-PAGE on 12% gels, and transferred to nitrocellu-
lose membranes (Schleicher and Schuell, Keene, NH). Nonspe-
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cific binding sites of themembranes were blocked by 5% nonfat
milk in PBS-T solution (phosphate-buffered saline containing
1% Tween 20). The primary antibodies in the different experi-
ments were monoclonal anti-HA (HA.11, Covance, Princeton,
NJ) 3000 in PBS-T containing 0.5% nonfat milk, rabbit poly-
clonal anti-calcineurin A (PP2B-A, H-209, sc-9070, Santa Cruz
Biotechnology, Santa Cruz, CA) 500 in PBS-T containing 1%
bovine serum albumin (BSA), or monoclonal anti--tubulin
isotype III IgG (SigmaT5076) diluted 5000 in PBS-T contain-
ing 1%BSA.The secondary antibodieswere anti-mouse or anti-
rabbit antibodies, respectively, (horseradish peroxidase-conju-
gated IgG from goat, R05071 or R05072, Advansta,Menlo Park,
CA) diluted 5000 or 10,000 in PBS-T containing 0.5% non-
fat milk. The membranes were washed once after blocking and
four to six times after the antibodies for 5–20 min in PBS-T.
The bands were visualized by the enhanced chemilumines-
cence detection method (WesternBright ECL HRP, Advansta)
according to the manufacturer’s instructions. Densitometry
analysis was performed with ImageJ 1.47v software written by
Wayne Rasband (Research Services Branch, NIH, Bethesda,
MD).
In Vitro Dephosphorylation of Radioactively Labeled Phos-
phoprotein Substrates—GST-hTRESK(174–280), GST-hTRESK-
(174–280)-AQAP, GST-mTRESK(164–292) and GST-
mTRESK(164–292)-AQAP fusion proteins immobilized on
10 l of glutathione-agarose were phosphorylated with Trx-
His6-MARK2-T208E for 1 h at 30 °C in 50l volume of solution
B containing (in mM): Tris-HCl 50 (pH 7.5), MgCl2 5, EGTA 2,
-mercaptoethanol 1.4, PMSF 0.5, benzamidine 0.5, supple-
mented with 20 M Na2ATP and 100 kBq [32P-]ATP. Prepa-
ration of the thioredoxin-hexahistidine-tagged constitutively
activeMARK2 kinase, containing the T208E phospho-mimick-
ing activator loop mutation, has previously been described (8).
(MARK2 phosphorylates the functionally relevant calcineurin-
substrate residues Ser-274 and Ser-276 inmouseTRESK,which
correspond to Ser-262 and Ser-264 in the human channel.)
Subsequently, the radioactively labeled proteins were
dephosphorylated with mouse brain cytosol for different time
periods from 0 to 60 min. The cytosol was prepared as detailed
in the “GST Pulldown Assay” section, but one brain was
homogenized in 4 ml of solution A. This substantial dilution of
the cytoplasm sufficiently slowed down the rate of dephosphor-
ylation, enabling the analysis of its kinetics. Cytosol from one
brain was used for 18 dephosphorylation reactions (10l resin/
reaction). The cytosol was supplemented with 1 mM CaCl2 or 2
mM EGTA in the different reactions. The reactions were
stopped by rapidly washing the resin twice with 1ml solution C
containing (in mM): Tris-HCl 20 (pH 7.5), NaCl 50, -mercap-
toethanol 1, followed by elution of the proteins from the resin
with sample buffer and separation on 12% SDS-PAGE gels. The
gels were stained with Coomassie Brilliant Blue, and their
radioactivity was detected with phosphorimager (GS-525,
Bio-Rad).
Statistics and Calculations—Data are expressed as means
S.E. Statistical significance was estimated by Student’s t test for
independent samples. The statistical difference was considered
to be significant at p 0.05.
RESULTS
Combined Mutations of the PQIIIS and LQLP Sites Are
Required to Prevent TRESK Regulation—Functional relevance
of the PQIIIS calcineurin docking motif of human TRESK (Fig.
1A) has not yet been investigated. To gradually disintegrate the
binding site, we designed three mutants: PQIIIA, PQIIAS, and
FIGURE 1. Combinedmutations of the PQIIIS and LQLP sites are required
for the complete elimination of the calcium-dependent activation of
humanTRESK.A, transmembrane topologyof humanTRESK subunit and the
PQIIIS and LQLP calcineurin docking motifs are illustrated. The regulatory
serine residues of the channel are shown in the vicinity of the LQLP site. (The
drawing is not to scale.) B, Xenopus oocytes expressing wild type (PQIIIS, wt.)
or mutant (PQIIIA, PQIIAS and PQAAAS) TRESK channels were stimulated with
the calcium ionophore ionomycin (0.5 M, Iono.) after verifying the insensi-
tivity of the basal K currents to benzocaine (1 mM, Benzo.). The extracellular
[K] was changed from 2 to 80 mM and back as indicated above the graph.
The currents were measured at 100 mV by two-electrode voltage clamp,
and normalized to their resting value in 80 mM [K]. Note that the mutations
of the PQIIIS site gradually deteriorated but did not completely eliminate the
activation; thePQAAASmutantwas activatedmore than2-foldby ionomycin.
Thegray error bars represent S.E.C, normalized activation in response to iono-
mycin (0.5 M) is shown for three different TRESK constructs, all containing
the PQAAAS mutation. The LQLP motif was not modified in TRESK-PQAAAS
(see TLQLPP, wt. curve); it was disintegrated by AQAP mutation in TRESK-
PQAAAS-TAQAPP (TAQAPP curve); or it was substituted with the correspond-
ing sequence of NFATc1 (NFAT2) in TRESK-PQAAAS-YLAVPQ (YLAVPQ curve).
Maximum activation levels at the end of the stimulation with ionomycin are
indicatedby dashed lines for the differentmutants, as labeled on the right side
of the panel. Note that the combined mutations of the PQIIIS and LQLP sites
eliminated the calcium-dependent regulation (TAQAPP curve), but YLAVPQ
functionally substituted for the TLQLPP sequence of TRESK (YLAVPQ curve).
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PQAAAS. The mutations (in the listed order) progressively
deteriorated the activation of the channel evoked by high (0.5
M) concentration of ionomycin (Fig. 1B). However, in sharp
contrast to the previously reported similar PQAVADmodifica-
tion of mouse TRESK (12), the PQAAAS mutation of the
human channel failed to eliminate the activation. Human
TRESK-PQAAAS was still activated more than 2-fold by the
elevation of cytoplasmic [Ca2]. (The activation of the
PQAAASmutant was significantly smaller than that of the wild
type channel, 2.4 0.3-fold versus 11.0 1.4-fold, respectively,
n 10 in both groups, p 104, Fig. 1B). The PQAAASmuta-
tion interfered with the calcineurin-dependent activation pro-
cess. The apparently reduced activation was not the conse-
quence of enhanced basal channel activity as indicated by the
equally low benzocaine-sensitivity of wild type and PQAAAS
mutant TRESK (Fig. 1B). (Benzocaine specifically inhibits the
activated TRESK current in Xenopus oocytes (12).)
Because the PQAAAS mutation alone did not completely
prevent the calcium-dependent activation of human TRESK,
we searched for another calcineurin-binding site in the chan-
nel. We examined the LQLP sequence, which is similar to the
LXVP calcineurin-binding consensus motif, and is located in
the vicinity of the serines targeted by the phosphatase (Fig. 1A).
The two leucines of the LQLP motif were replaced by alanines
in TRESK-PQAAAS. This additional AQAP mutation abol-
ished the residual activation. TRESK-PQAAAS-AQAP has not
been affected by ionomycin (1.07  0.03-fold change of K
current), whereas TRESK-PQAAAS was activated 2.27 0.15-
fold (n 12 in both groups, p 107, Fig. 1C). This indicates
that the LQLP motif mediates the residual calcineurin-depen-
dent activation, if PQIIIS is disabled.
If the LQLP site of TRESK functions analogously to the LxVP
calcineurin-docking motif then its replacement with a canoni-
cal LXVP sequence should also reproduce calcium-dependent
regulation. To test this assumption, we replaced the TLQLPP
sequence of TRESK-PQAAAS with YLAVPQ from NFATc1
(NFAT2). We modified a region of six amino acids, since it has
been reported that the tyrosine located N-terminally to LxVP
also contributes to the binding of calcineurin (19), whereas the
C-terminal second proline may interfere with the association
(22). TRESK-PQAAAS-YLAVPQ was activated identically to
TRESK-PQAAAS in response to ionomycin (Fig. 1C), indicat-
ing that the canonical LXVP motif from NFAT functionally
substituted for the wild type LQLP sequence.
The AQAP Mutation Slows Down the Activation of Human
TRESK Evoked by High Calcium, and Also Interferes with the
Activation of the Mouse Channel—The contribution of the
LQLP site to the calcium-dependent regulation was also exam-
ined by the AQAP mutation in the context of the wild type
channel. The amplitude of the activation of human TRESK-
AQAP in response to ionomycin (0.5 M) was not significantly
different from that of wild type TRESK (4.8 0.5-fold (n 21)
versus 6.2  0.6-fold (n  19), respectively, p  0.08, Fig. 2A).
However, the activation was decelerated by the AQAP muta-
tion, as illustrated in Fig. 2B on a shorter time scale. At the time
point indicatedwith anasterisk, the degrees of partial activation
during the application of the ionophore were significantly dif-
ferent between the AQAPmutant (3.1 0.3-fold) and the wild
type channel (4.9  0.6-fold, p  0.01, Fig. 2B). The rates of
activation in the two groups (calculated as % activation/second)
were also statistically different (data not shown). Thus the
AQAPmutation clearly slowed down the activation in response
to the robust elevation of [Ca2] induced by high concentration
of ionomycin, although the final level of activation was only
FIGURE2.TheAQAPmutationslowsdowntheactivationofhumanTRESK
evoked by high concentration of ionomycin, but the inhibitory kinase
reaction is not affected by this mutation. A, cells expressing wild type or
AQAPmutant TRESK channels were stimulated with high (0.5M) concentra-
tionof ionomycin (as indicatedby thehorizontal black bar). Recovery fromthe
activation was evaluated by a long washout period in 80 mM extracellular
[K], as indicated above the graph. The activations of thewild type andAQAP
mutant channelswere not significantly different at the end of the stimulation
with ionomycin. B, activation kinetics of the currents (same as in panel A)
during the stimulation with ionomycin are plotted on a shorter time scale.
The AQAP mutation slowed down the activation process; the partial activa-
tion of the AQAP mutant is significantly smaller than that of the wild type
channel at the time point indicated with an asterisk. C, percent recovery val-
ueswere calculated from the recordings represented in panel A. The recovery
from activation was identical in the cases of the wild type and AQAP mutant
TRESK channels.
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mildly (if at all) affected. The AQAPmutation did not influence
the kinase activity responsible for the inhibitory re-phosphory-
lation of human TRESK, as indicated by the unaltered percent
recovery values during the long washout period following the
ionomycin-stimulation (Fig. 2C).
Mouse TRESK contains LQPP instead of the LQLP sequence
characteristic for the human channel. We decided to examine
whether LQPP destruction affects the activation of mouse
TRESK, especially because the similar LAPP site of the Regula-
tor of Calcineurin (RCAN1) was reported to interact with the
phosphatase (23). The effects of the AQAPmutation onmouse
TRESK were substantially different from those obtained in the
case of the human channel (see the average currents in Fig. 3A,
and the currents normalized to peak value in Fig. 3B). The basal
current ofmouse TRESKwas increasedmore than 3-fold by the
AQAP mutation (7.0  1.6 A), compared with the wild type
channel (2.0 0.6 A, n 4 in both groups, p 0.05, Fig. 3C).
The activation by ionomycin was smaller in the AQAP (1.8 
0.1-fold) than in the control group (5.1 1.0-fold, p 0.05, Fig.
3.D). The return of the K current to the resting state after the
stimulation with ionomycin, calculated as the recovery in per-
cent, was diminished by the AQAP mutation (8 4% recovery
for AQAP versus 48 6% for the wild type channel at the end of
the measurement, p  0.01, Fig. 3E). The impaired activation of
theAQAPmutant is compatiblewith the contribution of LQPP to
the calcineurin-dependent activation, however, the increased
basal current and reduced recovery from activation suggest that
the AQAPmutation may have also interfered with the inhibitory
kinase reaction targeting themouse channel.
The LQLP Site Is Required for the High Sensitivity of Human
TRESK to Calcium—The slow activation of human TRESK-
AQAP raised the suspicion that the LQLP site contributes to
the calcium-sensitivity of the channel. We investigated this
hypothesis by stimulating TRESK and its mutant versions with
stepwise increasing concentrations (50, 100, 200, and 500 nM)
of ionomycin (Fig. 4A). This stimulation protocol results in a
slow elevation of [Ca2] in the cytoplasm, suitable for the inves-
tigation of the response of TRESK to modest calcium levels.
The final [Ca2] at the end of this stepwise stimulation (in 500
nM ionomycin) could be lower than in the case of the prompt
application of the same ionophore concentration, because the
major source of calcium, the intracellular stores, are depleted
during the prolonged treatment of the cell (24, 25).
Wild type TRESKwas substantially activated by the stepwise
ionomycin stimulation (4.0 0.5-fold at the end of the 500 nM
step, n  10, Fig. 4A, wt. curve). However, TRESK-AQAP
mutant was much less sensitive to the modest elevation of
[Ca2] under identical conditions (1.6  0.1-fold activation,
FIGURE 3. In mouse TRESK, the AQAP mutation also interferes with the calcium-dependent activation. A, average currents of two groups of oocytes
expressingwild typeorAQAPmutantmouseTRESKareplotted. Thecellswere stimulatedwith ionomycin (Iono., 0.5M, as indicatedby thehorizontal blackbar)
in 80 mM extracellular [K] (as shown above the graph). Basal K currents were estimated as I0, maximum activations in response to ionomycin as I1, and the
recovery at theendof themeasurement as I2. The small nonspecific leak currentsmeasured in2mM [K
]were subtracted fromthevaluesof I0, I1 and I2 in further
calculations but not in this graph. (Only plus orminus error bars (gray, S.E.) are shown.) B, same currents as in panel Awere normalized to their peak values. The
major part of the variation of data in panel A came from the different channel expression of the oocytes, and the response to ionomycin was rather uniform
within the groups. C, average basal K currents of thewild type (wt.) and AQAPmutant (m.) channels (I0 in panel A) are illustrated in this columndiagram. Basal
currents of the AQAPmutant were significantly larger than those of the wild type channel.D, normalized activations (I1/I0) of the wild type, and AQAPmutant
channels were calculated from the same data as represented in panel A. The apparent activation of the wild type channel exceeded that of the AQAPmutant.
E, percent recovery from activation of the K currents at the end of the measurement (I2 in panel A) was calculated as indicated by the expression above the
columns. The AQAP mutation diminished the return of the K current to the resting state after the stimulation with ionomycin.
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n  12, p  104, Fig. 4.A, AQAP curve). The activation of
AQLP (L240A point) mutant was also attenuated (2.3  0.3-
fold, n  12, Fig. 4.A, AQLP curve); intermediate between the
wild type and AQAP. It is important to note that in the same
oocyte preparation the wild type and the AQAP mutant chan-
nels were strongly and identically activated by the prompt
application of 500 nM ionomycin, representing a high calcium
stimulus (3.8 0.4-fold and 3.9 0.7-fold, respectively, n 6
in both groups, curves not shown). These data clearly demon-
strate that the mutation of the LQLP site abrogated the
response of the channel to modest elevation of [Ca2], whereas
the sensitivity to high calcium was maintained.
To apply a more physiological stimulus than ionomycin,
TRESK was coexpressed with M1 muscarinic acetylcholine
(ACh) receptor. In this experiment, the effects of modest and
high [Ca2] levels could be tested in the same cell. Modest
elevation of [Ca2] was induced by stepwise increasing concen-
trations (1, 3, 10, and 30 nM) of carbachol. The final robust
calcium signal was evoked by 1M concentration of the agonist
(Fig. 4B). Modest receptor stimulation (steps up to 30 nM car-
bachol) activated wild type TRESK 5.4  0.9-fold (n  11, see
wt. in Fig. 4, B and C). The same stimulation resulted in much
weaker activation of TRESK-AQLP (2.4 0.5-fold, n 9, p
0.02,AQLP) andTRESK-AQAP (2.6 0.3-fold, n 8, p 0.03,
AQAP in Fig. 4,B andC). These data reinforce the conclusion of
the experimentwith ionomycin that the sensitivity of TRESK to
modest elevation of [Ca2] is reduced by the AQLP and AQAP
mutations.
In response to the robust stimulation of M1 receptor with 1
M carbachol, the relative activations of the AQLP (21.7 1.7-
fold, p  0.05) and AQAP mutants (18.6  2.0-fold, ns) were
equivalent to (or even higher than) that of the wild type channel
(15.0 2.1-fold, Fig. 4, B and D). This indicates that the calci-
um-dependent activation mechanism is also operational in the
AQLP and AQAP mutants, but high calcium is required for its
initiation. TRESK-AQLP and TRESK-AQAP were less acti-
vated by the modest elevation of [Ca2] than wild type TRESK
(I1/I0, Fig. 4, B and C), but the activation of the mutants in the
same cells in response to high [Ca2] was not less than that of
the wild type channel (I2/I0, Fig. 4,B andD); these data together
convincingly demonstrate that the sensitivity to calcium was
shifted by the AQLP and AQAPmutations. The relative activa-
tion of the mutants by high calcium exceeded that of the wild
type channel (Fig. 4D), because of their more prevalent basal
inhibitory phosphorylation. (Dephosphorylation of TRESK by
calcineurin could also be impeded by the mutation under rest-
ing (low) [Ca2] conditions.) After the high calcium stimula-
tion, the wild type and mutant channels attained a similarly
activated state as indicated by their similar benzocaine-sensi-
tivity (Fig. 4B).
The protein expression levels of wild type andAQAPmutant
HA-tagged TRESK channels appeared to be equal in the oocyte
plasma membrane (Fig. 5A). The different calcium-sensitivity
of wild type and AQAPmutant TRESK was independent of the
expression levels of the channel proteins (Fig. 5, B and C).
Mutations of the LQLP Site Are Also Effective in TRESK-PVI-
VIT Channel—We examined the calcium-dependent regula-
tion,whenPQIIISwas replaced by the PVIVIT sequence of high
calcineurin binding affinity (14, 15). The average currents of
TRESK-PVIVIT and the wild type channel appeared to be sim-
ilar (Fig. 6A). In fact, TRESK-PVIVIT was less activated than
FIGURE 4. Alanine substitutions in the LQLP site reduce the sensitivity of
human TRESK to calcium. A, cells expressing wild type (wt., LQLP) or mutant
(AQLP and AQAP) TRESK channels were stimulatedwith stepwise increasing (50,
100, 200, and500nM) concentrationsof ionomycinas indicatedby thehorizontal
blackbars.NotethattheAQAPmutantwasunresponsivetothemodestelevation
ofcytoplasmic [Ca2], insharpcontrast tothewildtypechannel.B,wild type(wt.),
AQLP and AQAPmutant TRESK channels were coexpressedwithM1muscarinic
receptor. Modest calcium signals were evoked by the application of progressively
increasing (1, 3, 10, and30nM) concentrations of carbachol as indicatedby thehori-
zontal blackbars. Subsequently, robust calciumsignalwas inducedby1Mconcen-
trationof the agonist. Finally the sensitivity tobenzocaine (1mM)was testedas indi-
cated by the horizontal gray bar. Note that the AQLP and AQAPmutants have not
beenactivatedby the lowconcentrationsof carbachol, but theywere responsive to
high calcium. (The green AQLP and red AQAP curves overlap.) C, cumulative activa-
tions of the wild type (wt.), AQLP and AQAP mutant channels by low (1–30 nM)
concentrations of carbachol were calculated as I1/I0. The wild type channel was
more strongly activated than the AQLP and AQAPmutants.D, activations of the
wild type, AQLP and AQAP mutant channels in response to the robust calcium
signal (1 M carbachol) were estimated as I2/I0. By high calcium, the AQLP and
AQAPmutants were activated similarly to (ormore than) thewild type channel.
LQLP Is aMajor Determinant of TRESK Activation
OCTOBER 24, 2014•VOLUME 289•NUMBER 43 JOURNAL OF BIOLOGICAL CHEMISTRY 29511
 at SEM
M
ELW
EIS U
N
IV
 O
F M
ED
ICIN
E on N
ovem
ber 24, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
TRESK in this experiment (7.0 0.8-fold (n 11) versus 11.5
1.4-fold (n  10), respectively, p  0.01, normalized currents
not shown). Thus the activation of the mutant did not exceed
that of wild type TRESK, despite of the experimentally
enhanced affinity of the binding site for calcineurin. In another
oocyte preparation, normalized activation of TRESK-PVIVIT
was not significantly different from that of the wild type chan-
nel (4.3  0.3-fold (n  11) versus 4.3  0.5-fold (n  10),
respectively, curves not shown). These results suggest that the
substitution of the native binding site with PVIVIT sequence
decreased the basal inhibitory phosphorylation of TRESK in
one oocyte preparation but not in the other. (Enhanced anchor-
age of calcineurin to TRESK-PVIVITmay result in the dephos-
phorylation of the channel under resting conditions, depending
on the characteristics of the cell preparation, e.g. the basal cyto-
plasmic calcium concentration.)
Next, we asked whether LQLP was simply an auxiliary bind-
ing site for calcineurin and whether its major mechanism of
action was to increase the overall affinity of TRESK for the
phosphatase. If so, then the effects of its loss-of-function
(AQAP) mutation could be compensated by the gain-of-func-
tion (PVIVIT) mutation of the main (PQIIIS) docking motif.
Therefore we examined the effects of the AQAP mutation in
TRESK-PVIVIT background (Fig. 6B). The AQAP mutation
substantially reduced the sensitivity ofTRESK-PVIVIT tomod-
est elevation of [Ca2] evoked by stepwise stimulation with
50–500 nM ionomycin (see AQAP (TRESK-PVIVIT-AQAP)
and LQLP (TRESK-PVIVIT) curves in Fig. 6.B; 1.96 0.17-fold
activation for TRESK-PVIVIT-AQAP versus 2.98  0.33-fold
for TRESK-PVIVIT, at the time point indicated with double
asterisk, n 12 for both groups, p 0.02). This indicates that
LQLP is a major determinant of the overall affinity of TRESK
for calcineurin (thus PVIVIT mutation cannot increase cal-
cineurin binding as much as AQAP decreases it) or the two
(PQIIIS and LQLP) sites are not functionally equivalent (and
cross-compensation is impossible because of their independent
functions).
TRESK activation was decreased by the reduction of the cal-
cineurin binding affinity of the PQIIIS site by alanine substitu-
tions (Fig. 1B). In contrast, the regulation of the wild type and
TRESK-PVIVIT channels were identical (or highly similar, Fig.
6A), despite of the order ofmagnitude difference between the in
vitro KD values (0.5 versus 5 M) of their PXIXI(T/S) sites for
calcineurin (14). Thus it is reasonable to assume that the bind-
ing of calcineurin to TRESK-PVIVIT is close to saturation
under resting conditions. It was interesting to find that despite
of this saturation, the calcium sensitivity of TRESK-PVIVIT
could be increased by replacing its native TLQLPP site with
YLAVPQ sequence of NFATc1 (compare YLAVPQ (TRESK-
PVIVIT-YLAVPQ) and LQLP (TRESK-PVIVIT) curves in Fig.
6.B, 2.06  0.25-fold activation for TRESK-PVIVIT-YLAVPQ
versus 1.38  0.06-fold for TRESK-PVIVIT, at the time point
indicated with an asterisk, n 12 for both groups, p 0.02). It
is evident from this result that calcineurin binds to YLAVPQ
sequence with higher affinity than to the native TLQLPP motif
of TRESK. It seems unlikely that YLAVPQ evoked its effect by
further increasing the association of calcineurin to the nearly
saturated TRESK-PVIVIT under resting conditions. It is more
probable that the LQLP and PQIIIS sites of TRESK are involved
in different phases of the activation process.
We have also examined the effect of the PVIVITmutation on
the sensitivity of the channel to modest elevation of [Ca2]. In
one oocyte preparation no difference was found between the
activation of TRESK and TRESK-PVIVIT; the curves com-
pletely overlapped during the stepwise 50–500 nM ionomycin
FIGURE 5. The effect of the AQAPmutation is independent of the expres-
sion levels. A, expression levels of TRESK channels containing the wild type
(LQLP, wt.) sequence or the AQAP mutation in their intracellular loops, and
the influenza hemagglutinin epitope (HA) at their C termini, were compared
by anti-HA immunoblots. Expression levels of the LQLP (wt.) and AQAP con-
structs were similar both in the case of the human (hTRESK) and the mouse
(mTRESK) channels. Control membrane preparations were prepared from an
identical number of non-injected oocytes as used for the groups expressing
hTRESK-HA and hTRESK-HA-AQAP (n 17, 17) or mTRESK-HA and mTRESK-
HA-AQAP (n 40, 40). Identical amounts of injected cRNAs of the respective
constructs were verified on denaturing agarose gels and identical protein
content of the membrane preparations were checked by SDS-PAGE (not
shown). B, expression levels of hTRESK (wt.) and hTRESK-AQAP (AQAP) were
controlled by adjusting the amounts of cRNAs injected into the oocytes (as
indicated on the right side). The five groups of cells (n 22 forwt.(1x) and n
11 or 12 for the other four groups), characterized by basal current amplitudes
varying in line with the injected cRNA quantity, were stimulated by stepwise
increasing concentrations of ionomycin (as in Fig. 4A). C, normalized currents
from the same five groups of oocytes as in panel B. Note that the calcium
sensitivity of the wild type and AQAP channels is independent of the expres-
sion levels. Thewild type (blue,green, and red) and theAQAP (purple andolive)
curves, respectively, overlap.
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stimulation (curves not shown, 5.4  0.8-fold (n  9) versus
4.8 0.8-fold (n 13) activation at the end of the stimulation,
respectively).
In another cell preparation, however, we could detect the
difference: the PVIVIT mutant exhibited enhanced sensitivity
to modest stimulation (compare wt. (TRESK) and PVIVIT
(TRESK-PVIVIT) curves in Fig. 6C; 1.48 0.05-fold activation
for TRESK (n 20) versus 1.82 0.14-fold for TRESK-PVIVIT
(n 18), at the time point indicated with an asterisk, p 0.02).
In the same cell preparation, we have also examined the
effect of the PVIVIT mutation in TRESK-AQAP background.
Interestingly, however, the PVIVIT mutation did not increase
the sensitivity of TRESK-AQAP to modest [Ca2] (compare
AQAP andPVIVITAQAP curves in Fig. 6C). In high (200–500
nM) [ionomycin], the two curves deviated, although the differ-
ence did not reach significance (2.37 0.28-fold activation for
TRESK-AQAP (n  11) versus 2.97  0.38-fold for TRESK-
PVIVIT-AQAP (n 14), at the end of themeasurement). Thus
the effect of the PVIVIT mutation on the sensitivity of TRESK
to modest [Ca2] depended on the intact LQLP sequence.
Calcineurin Binds to the LQLP Site of TRESK in Vitro; the
Interaction Is Calcium-dependent—Although the above func-
tional data indicate the importance of the LQLP site in the
regulation of TRESK, formal evidence is required to verify that
LQLP interacts with calcineurin. To this end, we performed
GST pulldown experiments frommouse brain cytosol with the
cytoplasmic loop of human TRESK (amino acids 174–280) and
also with the AQLP and AQAP mutant versions of this bait
protein (Fig. 7A). The interaction of these constructs with cal-
cineurin was tested in the presence or absence of calcium. We
have previously reported (26) that the two intense bands of
proteins interacting with the wild type bait were identified by
mass spectrometry analysis as calcineurin A subunit and tubu-
lin (see lane 4 in Fig. 7A; CnA and Tub). The AQLP and AQAP
mutations drastically reduced the binding of calcineurin to
TRESK loop in the presence of calcium (compare lanes 5 and 6
to lane 4 in Fig. 7A). This indicates that the LQLP site is amajor
determinant of the interaction betweenTRESK and calcineurin
in the presence of calcium.
The amount of calcineurin interacting with the wild type
TRESK fragment was lower in the absence than in the presence
of calcium (compare lane 1 to 4 in Fig. 7A). The relatively weak
binding of calcineurin was not further reduced by the AQLP
andAQAPmutations in the absence of calcium (compare lanes
2 and 3 to lane 1 in Fig. 7A). Identical results were obtained
when the experiment in Fig. 7Awas repeated with another bait
protein, GST-hTRESK(174–247), which contained the PQIIIS
and LQLP sites, but not the region of the Ser-252, Ser-262,
Ser-264 substrate serines of calcineurin (results not shown).
These data suggest that the binding of calcineurin to the LQLP
site is calcium-dependent.
FIGURE 6. The loss- and gain-of-function mutations of the LQLP site are
effective in theTRESK-PVIVITcontext; thePVIVITmutation ismoreeffec-
tive in the wild type (LQLP) than in the AQAP background. A, average
currents of oocytes expressing wild type TRESK (wt., gray curve) or TRESK-
PVIVIT (PVIVIT, black curve) are compared. The PQIIIS site was replaced with
the PVIVIT sequence of high calcineurin-affinity in the TRESK-PVIVIT mutant.
The activation of the currents was evoked by ionomycin (0.5M, as indicated
by the horizontal black bar). B, normalized responses of three different
mutants of TRESK to stepwise increasing (50, 100, 200, and 500 nM) concen-
trations of ionomycin are illustrated. The PQIIIS motif was replaced with PVI-
VIT in all threemutants. TheLQLPmotifwasnotmodified in TRESK-PVIVIT (see
the LQLP curve); it was disabled by AQAP mutation in TRESK-PVIVIT-AQAP
(AQAP curve); or the TLQLPP region was replaced by the corresponding frag-
ment of NFAT in TRESK-PVIVIT-YLAVPQ (YLAVPQ curve). The partial activation
of TRESK-PVIVIT-YLAVPQ (YLAVPQ) was significantly higher than that of
TRESK-PVIVIT (LQLP) at the time point indicated with an asterisk, whereas the
partial activation of TRESK-PVIVIT-AQAP (AQAP) was significantly reduced,
comparedwith TRESK-PVIVIT (LQLP) at the time point indicatedwith a double
asterisk. C, normalized responses of TRESK (wt.), TRESK-PVIVIT (PVIVIT), TRESK-
AQAP (AQAP), and TRESK-PVIVIT-AQAP (PVIVITAQAP) to the same stimula-
tion as in panel B are plotted. The partial activation of TRESK-PVIVIT (PVIVIT)
was significantly higher than that of the wild type (wt.) channel at the time
point indicated with an asterisk. In contrast, the sensitivity of TRESK-AQAP
to low calcium was not enhanced by the PVIVIT mutation (compare
PVIVITAQAP to AQAP curve). (Only plus or minus error bars are shown. The
currents in panel C were measured from another oocyte preparation than
those in panel B.)
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In the above pulldown assays, the cumulative effects of the
PQIIIS and LQLP sites determined the interaction of the bait
with calcineurin. In order to investigate the LQLP site sepa-
rately, PQIIIS was removed from the bait protein by truncation.
We could detect the calcium-dependent pulldown of calcineu-
rin with this truncated TRESK fragment of amino acids 232–
280, containing only the LQLP site but not PQIIIS (compare
lane 2 to 3 in the enlarged inset of Fig. 7B). Nevertheless, the
interaction of calcineurin with LQLP alone was much weaker
than that with fragment 174–280 containing both binding sites
(in the presence of calcium, compare lane 3 to 5 in Fig. 7B).
Thereforewe examinedwhether the occupation of the PXIXIT-
binding site of calcineurin allosterically increases the affinity of
the phosphatase for an LxVP ligand. Saturation of the PXIXIT-
binding site of calcineurin with VIVIT peptide (15) failed to
allosterically promote the association of the phosphatase to the
bait containing only the LQLP motif (lanes 3 and 4 in Fig. 7B).
Thus, in this respect, the mechanisms of binding to the two
types of motifs are not coupled; however, the interaction of
calcineurin with the LQLP site was verified to be calcium-de-
pendent also in the case of the bait protein, which does not
contain the PQIIIS motif.
Identity of the calcineurin A band was also verified byWest-
ern blot using specific antibody (Fig. 7, C andD). Densitometry
and statistical analysis indicated that more calcineurin bound
to the LQLP than to the AQAP construct (Fig. 7, D–F).
The Intracellular Loop of Wild Type TRESK Is More Rapidly
Dephosphorylated in Vitro Than the AQAP Mutant—The dif-
ferent GST-TRESK constructs were radioactively labeled by
phoshphorylation with recombinant MARK2 kinase. The
kinetics of calcineurin-dependent dephosphorylation was esti-
mated by the subsequent application of diluted brain cytosol to
these phosphoproteins immobilized on glutathione agarose
(Fig. 8). The human or mouse wild type TRESK sequences
(including LQLP or LQPP, respectively) were more rapidly
dephosphorylated in a calcium-dependent manner than the
AQAPmutant versions of these substrate proteins. This in vitro
result confirms that the altered dephosphorylation is responsi-
ble for the difference between the functional data of the wild
type and AQAP mutant channels, obtained in the oocyte
measurements.
FIGURE 7. The LQLP motif of TRESK is a calcineurin binding site. A, GST
pulldown assays were performed from mouse brain cytosol with the cyto-
plasmic loopof humanTRESK (wild type fragment 174–280, LQLP, lanes 1 and
4), and the AQLP (AQLP, lanes 2 and 5) andAQAP (AQAP, lanes 3 and 6) mutant
versions of this bait protein. The binding of calcineurin was tested in the
presence (1 mM, lanes 4–6) or in the absence of calcium (2 mM EGTA, lanes
1–3). The two known interactingproteinsweremarkedon the right sideof the
Coomassie Blue-stained gel as tubulin (Tub.) and calcineurin A subunit (CnA).
Note the abundant binding of calcineurin to the wild type bait protein in the
presenceof calcium (lane4) and thedrastic reductionof the interactionby the
AQLP andAQAPmutations (lanes 5 and 6) or by the chelation of Ca2 (lane 1).
(The bait protein preparations contained several incompletely translated
fragments in addition to the full-length product below 47 kDa, and a promi-
nent contaminating bacterial protein band below 86 kDa.) B, GST pulldown
reactions were performed with fragment 232–280 retaining only the LQLP
motif (lanes 1–4), or with fragment 174–280 containing both intact (PQIIIS
and LQLP) binding sites (lanes 5 and 6). The additionofmousebrain cytosol to
the reaction (lane 1 is an only bait control), the presence of calcium (1 mM) or
EGTA (2mM) and the administration of VIVIT peptide (75M) were controlled
as indicated in the table. The interacting partners, tubulin (Tub.) and calcineu-
rin A (CnA), are labeled on the right side, and a faint contaminating band from
the purification of fragment 232–280 is indicated with asterisks. The relevant
regionof theCoomassie Blue-stainedgelwasmagnified and the contrastwas
adjusted for better visibility of the bands in the inset below the table. Note
that the binding of calcineurin to fragment 232–280 was detected in the
presence (lane 3), but not in the absence of calcium (lane 2). VIVIT peptide
attenuated the interaction of calcineurin with fragment 174–280 (lane 5 ver-
sus 6), but did not enhance the binding of calcineurin to fragment 232–280
(lane 3 versus 4). C, four pairs of independent pulldown reactions were per-
formed with GST-hTRESK(174–280) (wt.) and GST-hTRESK(174–280)-AQAP
mutant (m.) as in lanes 4 and 6 of panel A. The samples were analyzed on
SDS-PAGE gel followed by Coomassie Blue staining. D, immunoblot of the
same samples as in panel C with anti-calcineurin A (anti-CnA) antibody. E,
densitometry curveof the immunoblot inpanelD, and columndiagramof the
densitometry counts. Significantly more calcineurin interacted with the wild
type (LQLP) construct than with the AQAP mutant (p 105). F, same mem-
brane as in panel D was stripped and re-probed with anti-tubulin 3 (anti-
TUBB3) antibody. The loaded amounts of the AQAP pulldown reactions were
not less than those of the wild type.
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DISCUSSION
K2P background potassium channels are responsible for
maintaining the highly negative resting membrane potential in
different excitable cell types (1–5). Their regulation by voltage-
independent mechanisms is of importance, since K2P channels
generally determine the responsiveness of the cell to different
excitatory stimuli and can also efficiently counter massive
depolarization. The fifteen members of the K2P family are tar-
geted by diverse regulatory mechanisms conferring tempera-
ture-, mechano-, or pH-sensitivity in the physiological range
and modulated by a great variety of signaling pathways and
protein interactions. The different excitable cell types typically
express a specific subset of these channels to meet the regula-
tory requirements for their functions.
TRESK (K2P18) is abundantly expressed in the pseudouni-
polar neurons of dorsal root, trigeminal and other sensory gan-
glia (7, 27–31), together with a major fraction of TREK-2
(K2P10) and other minor K2P components (27, 32). TRESK is
present in the plasma membrane of the cell body, as its single
channel openings were detected in excised membrane patches
of dorsal root ganglion (DRG) neurons (27), and perikaryons
isolated form TRESK knock-out mice showed altered electro-
physiological properties (28). TRESK function appeared to be
partially compensated by other K channels in these cells (28),
and a TRESK-related phenotype has not yet been described in
the knock-out animals apart from a slightly increasedmortality
rate following anesthesia (33). Rat sciatic nerve axotomy
induced hyperexcitability of nociceptive DRG neurons by
decreasing TRESKmRNA expression (30), and themutation of
humanTRESKwas reported to be linked to a rare formof famil-
ial migraine (7), suggesting a role for the channel in pain disor-
ders (31, 34–36).
Pharmacological separation of TRESK current from those of
the other K2P channels in native cells has not yet been ade-
quately resolved; TRESKcurrent is usually approximated by the
current component sensitive to the relatively nonspecific inhib-
itors lamotrigine (31, 36, 37), hydroxy--sanshool (38) or
isobutylalkenyl amide (IBA) (30). Furthermore, it is a method-
ological challenge to reliably measure calcium-dependent
TRESK activation under whole-cell patch clamp conditions
(even in HEK cells overexpressing the channel (see Ref. (8)).
Therefore we examined TRESK regulation by two-electrode
voltage clamp of Xenopus oocytes, in a system characterized by
minimally altered cytoplasmic composition during the mea-
surement. This approach made it possible to investigate the
effects of PXIXIT- and LXVP-like site modifications on a cal-
cineurin-target protein with unprecedented time resolution.
Several lines of evidence indicate that the LQLP sequence
functions as an LXVP-like calcineurin-docking site in TRESK.
The AQAPmutation reduced the binding of calcineurin to the
cytoplasmic loop of TRESK in vitro. A fragment of the loop
containing only the LQLP but not the PQIIIS site also pulled
down the phosphatase from brain cytosol. The interaction
between LQLP and calcineurin was calcium-dependent, an
established property of LXVP sites (20–22). These in vitro
results are in good accordance with the functional data: alanine
substitutions in the LQLP site reduced the sensitivity of TRESK
to calcium, whereas the LQLP sequence was functionally sub-
stituted by the canonical LXVP motif from NFAT. Thus LQLP
is the first reported LXVP-like calcineurin-docking site, which
contains leucine instead of valine in the third position of the
motif. Accordingly, the LXVP consensus sequence could be
modified to LX(V/L)P.
Perhaps the first example of enhanced dephosphorylation by
calcineurin of a short peptide fragment containing anLXVP site
was documented in the case of DLDVPIPGRFDRRVSVCAE
sequence of PKA regulatory subunit RII, although it was not
evident in 1986 that the effect depended on the LxVP motif
(39). This important example indicates that LXVP can be
located relatively close to the dephosphorylated residue; the
two sites are separated only by 9 amino acids. Therefore it is
reasonable to assume that calcineurin, while it is docked to the
LQLP site, can also dephosphorylate the regulatory serines of
human TRESK in distances of 8, 18 and 20 residues.
The LXVP motif was first described in NFAT as a second
binding site for calcineurin, in addition to PXIXIT (17–19).
Interestingly, however, the 13 residues dephosphorylated by
calcineurin in NFAT are not even C-terminal to the LXVP site,
but they are distributed along a more than 200 amino acid long
FIGURE 8. The in vitro calcium-dependent dephosphorylation of thewild
type TRESK sequence is more rapid than that of the AQAP mutant.
A, different substrate proteins, GST-hTRESK(174–280) (hTRESK), GST-
hTRESK(174–280)-AQAP (hTRESK-AQAP), GST-mTRESK(164–292) (mTRESK),
GST-mTRESK(164–292)-AQAP (mTRESK-AQAP) immobilized on glutathione
resin, were in vitro phosphorylated in the presence of [32P-]ATP by constitu-
tively active recombinant MARK2 kinase (Trx-His6-MARK2-T208E). Subse-
quently, theyweredephosphorylatedwithdilutedmousebrain cytosol in the
presence or absence of calcium for different time periods (as indicated below
the autoradiograms of SDS-PAGE gels). Note that the wild type TRESK
sequencesweremore rapidly dephosphorylated than theAQAPmutants (see
the 0, 15, 30, 60 min reactions in the left 4 columns of bands). For statistical
analysis, three independent pairs of dephosphorylation reactions were per-
formed in the presence or absence of calcium for 60min with each substrate
proteins (see the right 6 columns of bands). B, calcium-dependent dephos-
phorylation (illustrated in the column graph in percent) was calculated from
the radioactive counts of these bands in panel A. Thewild type versions of the
substrate proteins were dephosphorylated more efficiently than the AQAP
mutants (p 0.002 for both hTRESK and mTRESK).
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region positioned between the (N-terminal) PXIXIT and the
(C-terminal) LXVPmotifs (40). KSR2 (Kinase Supressor of Ras
2) also contains its 3 dephosphorylated residues N-terminally
to its LXVP site, distributed in a region of about 200 amino acids
(41). In contrast, the two substrate serines of human RCAN1
(Regulator of calcineurin 1) are located C-terminally to the
LAPP motif in distances of 8 and 12 residues (23). In dynamin-
related protein 1 (Drp1), LXVP and the phosphoserine are sep-
arated by 7 residues (42). This suggests that the mode of action
of the LXVP-like binding sites may vary in the different cal-
cineurin substrates. As indicated by the example of PKA RII
peptide (20, 39), calcineurin, while it is docked to the LXVP-like
site, can dephosphorylate substrate residues located nearby in
the C-terminal direction in RCAN1, Drp1 and human TRESK
(we may call them mode 1 LXVP substrates of calcineurin).
However, in the other group of substrates (mode 2), as inNFAT
andKSR2, three-dimensionalmovement of the substrate-phos-
phatase complex is required to bring the different substrate
residues to the proximity of the active site, or calcineurin may
dissociate from the LXVP motif during dephosphorylation.
Rodent TRESK contains LQPP instead of LQLP. This is
highly similar to LAPP of RCAN1, which is a verified calcineu-
rin-docking site (23). The significance of LQPP in the anchor-
ing of calcineurin could not be unequivocally determined in the
oocyte measurements, since the mutation of the motif also
caused calcineurin-independent effects; presumably it inter-
fered with the action of the TRESK-inhibitory kinase, or influ-
enced the intrinsic channel activity of the protein. The contri-
bution of the LQPP motif to the action of calcineurin was
clearly demonstrated by the in vitro dephosphorylation exper-
iment, where the AQAP mutation diminished dephosphory-
lation. Nevertheless, the PQAVAD mutation completely elim-
inated the activation of mouse TRESK (12), suggesting that
LQPP is less effective in the mouse than LQLP in the human
channel. These data indicate that the measurement of several
kinetic parameters (e.g. basal activity, relative activation, rate of
activation, recovery kinetics from activation) may be required
for the interpretation of the effects of LXVP-like sitemutations.
It is apparent that several aspects of the kinase and phosphatase
reactions are different between the human and mouse
orthologs, and care must be taken if data are extrapolated from
rodent experimental models to the physiology of human
TRESK.
Mutation of LQLP to AQAP in human TRESK did not sig-
nificantly influence the final level of activation in response to
high calcium, but slowed down the regulatory process. AQAP
mutation reduced the sensitivity of the channel to calcium, and
this effect was also detected in TRESK-PVIVIT. Furthermore,
the calcium sensitivity of TRESK-PVIVIT could be increased
by the substitution of the native TLQLPP sequence with
YLAVPQ, the canonical LXVP site of NFAT. The PVIVIT
mutation itself could also increase the sensitivity of TRESK to
modest elevation of [Ca2] in an oocyte preparation probably
characterized by relatively low occupancy of the PQIIIS cal-
cineurin-binding site. However, this effect of the PVIVITmuta-
tion required the presence of the intact LQLP site. Sensitivity of
TRESK-AQAP to modest [Ca2] has not been increased by the
PVIVIT mutation in the same cell preparation. These results
suggest that the function of the LQLP site is not equivalent to
that of PQIIIS, and themechanisms of action of these sites need
further explanation. Regarding that the binding of calcineurin
to the LQLP site is calcium-dependent, but it is generally
accepted in the literature that the docking of the phosphatase to
PXIXIT-like motifs is independent from [Ca2] (13, 14, 43, 44),
a plausible explanation for the resultsmay be that the binding of
calcineurin to TRESK is a process of two consecutive steps.
Calcineurin is anchored to PQIIIS under resting conditions.
When the cytoplasmic [Ca2] is elevated, calcineurinmay dock
to the LQLP motif and become adequately positioned for the
dephosphorylation of the regulatory serines (Fig. 9). In other
words, PQIIIS may be mainly responsible for the availability of
calcineurin for the reaction, whereas LQLP for the efficient tar-
geting of the activated phosphatase to the specific substrate
serines. If LQLP is disabled then the reaction slows down, and
FIGURE 9. Interplay of the PQIIIS and LQLP calcineurin-dockingmotifs in the regulation of human TRESK. A, calcineurin binds to the PQIIIS motif under
resting conditions, depending on the concentration of the phosphatase in the cell, but independently of the cytoplasmic [Ca2]. B, LQLP-binding site of
calcineurinbecomesavailable in response to the calciumsignal. TheLQLPmotif binds to calcineurin andbrings theadjacent substrate residues in theproximity
of the active site of the enzyme.
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this can be especially detrimental for the regulatory process,
when the phosphatase spends only a limited fraction of time in
the activated state in the case of modest stimulation. In accord-
ance with the above model, LQLP may also attract a small
amount of active calcineurin from solution or yet uncharacter-
ized weak binding sites during the stimulation, andmediate the
activation of TRESK-PQAAAS mutant.
In summary, the LQLP site is a major determinant of the
interaction of calcineurinwith humanTRESK, and significantly
contributes to the calcium-sensitivity of the channel. Our
results also provide general insight into the functions of the
PXIXIT- and LXVP-like sites, and may impact on the research
of other calcineurin-target proteins containing these motifs.
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